2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Sunday, December 13, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Access, Representation, Population Health, Technology and Procedures, Assays, Imaging, Omics Technologies, Serologic Tests, Bioinformatics, Profiling, Treatment Considerations, Supportive Care, Therapy Sequence, Biological Therapies, (CAR)-T Cell Therapies, Immunotherapy, Non-Biological Therapies, Chemotherapy, Women’s Health, Biological Processes, Apoptosis, Immune Mechanism, Molecular Biology, Clinical Practice (Health Services and Quality), Patient Safety, Quality Improvement, Quality of Care, Diseases, Bone Marrow Failure Syndromes, Genetic Disorders, Immunology, Immunodeficiency, White Blood Cell Disorders, Infectious Diseases, Viral, Lymphoid Malignancies, Lymphomas, Plasma Cell Disorders, Myeloid Malignancies, Indolent Lymphoma, Research, Fundamental Science, Translational Research, Clinical Research, Clinical Trials, Epidemiology, Health Outcomes Research, Real-World Evidence, Survivorship, Study Population, Human, Animal Model
PAPER

2991 DNA damage response CRISPR screens reveal UBE2A as a critical factor in the repair of alcohol-induced DNA damage

Zihe Qi, Habin Bea, BS2, Juhye Choi, MD3, Fan Yang, M.S.4, Valerie Kellett, BS5, Sangmoo Jeong, PhD6, Moonjung Jung, MD, MS7
1 Johns Hopkins University, Baltimore, Maryland, United States
2 Johns Hopkins University, Baltimore, Maryland, United States
3 Johns Hopkins University, Baltimore, Maryland, United States
4 Johns Hopkins University, Baltimore, Maryland, United States
5 Johns Hopkins University, Baltimore, Maryland, United States
6 Johns Hopkins University, Baltimore, Maryland, United States
7 Johns Hopkins University, Baltimore, Maryland, United States

Alcohol is a common source of DNA damage in humans. Its metabolic byproducts, acetaldehyde and reactive oxygen species (ROS), mutate hematopoietic stem cells. Multiple DNA repair pathways are required to clear alcohol-induced DNA lesions. However, the relative contribution of each DNA repair pathway to genome integrity in excessive alcohol use remains unclear. To fill this knowledge gap, we performed a pooled CRISPR screen focused on the DNA damage response (DDR) to elucidate the DNA repair pathways required for repairing specific DNA lesions caused by alcohol and its toxic metabolites in Jurkat cells, an acute T-cell leukemia cell line.

We performed a DDR-focused pooled CRISPR screen with and without alcohol treatment. We used Jurkat cells to test 0-, 10-, and 100-mM alcohol treatment to examine the role of low- (10 mM) and high-dose (100 mM) chronic alcohol exposure. We found that 10 mM alcohol treatment showed an identical growth rate compared with untreated conditions, while 100 mM alcohol treatment showed a slower growth rate, suggesting that 100 mM was sufficient to exert biological effects on Jurkat cells, while 10 mM was not.

The CRISPR screen showed that the baseline samples had highly concordant normalized sgRNA counts across samples, which were collected before the initiation of alcohol treatment. On the other hand, the final time point samples (after 14 population doublings) that were treated with 100 mM alcohol showed more significant differences compared with those that were untreated and 10 mM alcohol treated conditions. These findings suggest that high-dose alcohol treatment resulted in substantial differences in sgRNA abundance, suggesting the synthetic interaction between high-dose alcohol and DDR pathways. In line with these findings, there were no significantly depleted genes when comparing the untreated and 10 mM alcohol conditions. A volcano plot comparing untreated and 100 mM alcohol-treated conditions revealed six significantly depleted genes in the 100 mM alcohol condition, with UBE2A being the most significantly depleted gene. A radial plot of enrichment ratios from KEGG pathway analysis, calculated using WebGestalt with significantly depleted genes, showed that chronic exposure to 100 mM alcohol made Jurkat cells more dependent on non-homologous end joining (NHEJ), base-excision repair (BER), and Fanconi anemia (FA) pathways than other DNA repair pathways. These results suggest that chronic alcohol exposure at 100 mM induces oxidative DNA lesions and DNA crosslinks in Jurkat cells, ultimately leading to double-strand breaks, making cells vulnerable to loss of NHEJ repair proteins. 

Given the known role of UBE2A in the DNA damage tolerance pathway, we hypothesized that UBE2A allows Jurkat cells to proceed to active cell cycle despite the presence of alcohol-induced DNA lesions, and that the lack of UBE2A results in reduced cell cycle entry in the setting of alcohol exposure. To test this, we performed a flow-based cell cycle assay using bulk knockout cells edited by nucleofection of a ribonucleoprotein complex with Cas9 and either sgCTRL or sgUBE2A, with or without 100 mM alcohol in vitro treatment. We found that UBE2A knockout resulted in a significantly reduced proportion of cells in S phase in alcohol-exposed conditions, while there was only a trend toward reduced S phase in the absence of alcohol treatment. These findings suggest that UBE2A plays an important role in tolerating alcohol-induced DNA damage in Jurkat cells and allows them to proceed through the cell cycle despite the alcohol-induced DNA lesions. We will perform PCNA ubiquitination assays and DNA fiber assays to test whether UBE2A protects cells from alcohol through its role in PCNA ubiquitination and to visually inspect replication fork progression and speed affected by UBE2A knockout with or without alcohol exposure, respectively. These results will be presented at the 2026 ASH Annual Meeting.
Zihe Qi: No relevant conflicts of interest to declare.